Skip to content
★ Sign in to follow
JR
Total declarations
38
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (19 ops.)
€3.2M

Latest filing published 27 Mar 2019 for KYNTRA BIO, INC., €97k.

Filing timeline

BuySale
Jorma Routti

Insider track record

Disclosed buys
0
Disclosed sells
19
Signal history

Jorma Routti: trading record in brief

Jorma Routti discloses dealings in Kyntra Bio, Inc. to SEC (Form 4). We count 38 filings; the first trade dates from 19 November 2014 and the latest from 26 March 2019.

Every open-market trade on record is a sale: 19 sales worth €3.2M. The rest of the record consists of 1 share grant and 17 option exercises.

On 27 March 2019 came the latest disclosure, an option exercise for €304k in Kyntra Bio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Jorma Routti

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations38 total
  • ◇
    DirectorExecutivesKyntra Bio, Inc.
    110,040 USD11SEC
    6,000 shares@ US$18.343.6% of flowCommon StockSEC:0001209191-19-021482:0
  • ◇
    DirectorExecutivesKyntra Bio, Inc.
    343,800 USD12SEC
    12,000 shares@ US$28.6511.2% of flowCommon StockSEC:0001209191-19-021482:1
  • ◇
    DirectorExecutivesKyntra Bio, Inc.
    228,600 USD12SEC
    12,000 shares@ US$19.057.4% of flowCommon StockSEC:0001209191-19-021482:2
  • ◇
    DirectorExecutivesKyntra Bio, Inc.
    110,040 USD11SEC
    6,000 shares@ US$18.342.5% of flowCommon StockSEC:0001209191-18-050650:0
  • ▼
    DirectorExecutivesKyntra Bio, Inc.
    245,917 USD30SEC
    4,300 shares@ US$57.195.6% of flowCommon StockSEC:0001209191-18-050650:1
  • ▼
    DirectorExecutivesKyntra Bio, Inc.
    97,920 USD29SEC
    1,700 shares@ US$57.602.2% of flowCommon StockSEC:0001209191-18-050650:2
  • ◇
    DirectorExecutivesKyntra Bio, Inc.
    108,000 USD11SEC
    6,000 shares@ US$18.002.5% of flowCommon StockSEC:0001209191-18-046244:0
  • ▼
    DirectorExecutivesKyntra Bio, Inc.
    220,520 USD30SEC
    3,700 shares@ US$59.605.0% of flowCommon StockSEC:0001209191-18-046244:1
  • ▼
    DirectorExecutivesKyntra Bio, Inc.
    122,410 USD29SEC
    2,028 shares@ US$60.362.8% of flowCommon StockSEC:0001209191-18-046244:2
  • ▼
    DirectorExecutivesKyntra Bio, Inc.
    16,649 USD29SEC
    272 shares@ US$61.210.4% of flowCommon StockSEC:0001209191-18-046244:3
  • ◇
    DirectorExecutivesKyntra Bio, Inc.
    108,000 USD11SEC
    6,000 shares@ US$18.002.4% of flowCommon StockSEC:0001209191-18-042396:0
  • ▼
    DirectorExecutivesKyntra Bio, Inc.
    406,260 USD30SEC
    6,000 shares@ US$67.719.1% of flowCommon StockSEC:0001209191-18-042396:1
  • ◇
    DirectorExecutivesKyntra Bio, Inc.
    58,680 USD11SEC
    6,000 shares@ US$9.781.2% of flowCommon StockSEC:0001209191-18-037338:0
  • ▼
    DirectorExecutivesKyntra Bio, Inc.
    344,880 USD30SEC
    6,000 shares@ US$57.486.8% of flowCommon StockSEC:0001209191-18-037338:1
  • ◆
    DirectorExecutivesKyntra Bio, Inc.
    0SEC
    3,700 shares0Common StockSEC:0001209191-18-036520:0
  • ◇
    DirectorExecutivesKyntra Bio, Inc.
    58,680 USD11SEC
    6,000 shares@ US$9.781.1% of flowCommon StockSEC:0001209191-18-029578:0
  • ▼
    DirectorExecutivesKyntra Bio, Inc.
    282,600 USD30SEC
    6,000 shares@ US$47.105.5% of flowCommon StockSEC:0001209191-18-029578:1
  • ◇
    DirectorExecutivesKyntra Bio, Inc.
    35,700 USD11SEC
    6,000 shares@ US$5.950.7% of flowCommon StockSEC:0001209191-18-024694:0
  • ▼
    DirectorExecutivesKyntra Bio, Inc.
    64,274 USD29SEC
    1,400 shares@ US$45.911.2% of flowCommon StockSEC:0001209191-18-024694:1
  • ▼
    DirectorExecutivesKyntra Bio, Inc.
    215,280 USD29SEC
    4,600 shares@ US$46.804.1% of flowCommon StockSEC:0001209191-18-024694:2
  • ◇
    DirectorExecutivesKyntra Bio, Inc.
    21,000 USD11SEC
    6,000 shares@ US$3.500.4% of flowCommon StockSEC:0001209191-18-010955:4
  • ◇
    DirectorExecutivesKyntra Bio, Inc.
    21,000 USD11SEC
    6,000 shares@ US$3.500.4% of flowCommon StockSEC:0001209191-18-010955:0
  • ▼
    DirectorExecutivesKyntra Bio, Inc.
    64,148 USD29SEC
    1,193 shares@ US$53.771.2% of flowCommon StockSEC:0001209191-18-010955:1
  • ▼
    DirectorExecutivesKyntra Bio, Inc.
    104,160 USD29SEC
    1,907 shares@ US$54.622.0% of flowCommon StockSEC:0001209191-18-010955:2
  • ▼
    DirectorExecutivesKyntra Bio, Inc.
    160,950 USD29SEC
    2,900 shares@ US$55.503.0% of flowCommon StockSEC:0001209191-18-010955:3

25 of 38 declarations